Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Radiology and Oncology
Volume 47 (2013): Issue 1 (March 2013)
Open Access
Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies
Alessandro Tuzi
Alessandro Tuzi
,
Davide Lombardi
Davide Lombardi
,
Diana Crivellari
Diana Crivellari
,
Loredana Militello
Loredana Militello
,
Tiziana Perin
Tiziana Perin
,
Manuela La Grassa
Manuela La Grassa
,
Samuele Massarut
Samuele Massarut
and
Andrea Veronesi
Andrea Veronesi
| Feb 01, 2013
Radiology and Oncology
Volume 47 (2013): Issue 1 (March 2013)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Feb 01, 2013
Page range:
57 - 62
DOI:
https://doi.org/10.2478/raon-2013-0012
Keywords
breast cancer
,
docetaxel
,
epirubicin
,
neoadjuvant chemotherapy
This content is open access.